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Background: A program to strengthen general practice care for patients with chronic disease was offered in
Germany. Enrollment was a free individual choice for both patients and physicians. This study aimed to examine
the long-term impact of this program.
Methods: Two comparative evaluations were done, at 4 and 5 years (T1 and T2) after start of the program. In each
year, patients in the program were compared with patients in usual care. Measures were based on routinely collected
data and concerned 11 aspects of primary care and hospital care. Study groups were compared, using regression
analysis adjusted for confounders and clustering.
Results: Data on 1.187.597 and 1.591.017 eligible patients were available for the analysis for T1 and T2, respectively.
Compared to usual care, the program was associated with more visits to the GP per patient (adjusted difference at T2:
+1.98), more drugs prescribed per patient (+0.071), lower percentage of drugs that should be avoided (−0.699), and
lower yearly medication costs per patient (−85.39 euro). The number of referrals to ambulatory specialists, either with
or without referral from GP, was reduced at T2. In hospital care, the program was associated with fewer hospital admissions
per patient per year (−0.017) and fewer avoidable hospital admissions of all admissions (−1.165%). Total hospital costs were
slightly higher in T1, but lower in T2. Days in hospital and number of readmissions were lower at T2 only.
Conclusion: The program has increased the role of general practice in healthcare for patients who chose to be included in
the program of intensified general practice care.
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A wide range of programs and policies have been ap-
plied to improve healthcare for patients with chronic
diseases, often in research or demonstration projects. In
Baden-Wuerttemberg, a German federal state with about
10.7 million inhabitants, a program was introduced to
strengthen general practice care in the year 2008. This
program, which is still running, is targeted at enhancing
the role of general practice in healthcare for patients
with chronic diseases [1]. It emphasized pro-active, orga-
nized and evidence-based management of patient* Correspondence: Michel.Wensing@med.uni-heidelberg.de
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a framework for high-quality primary care [2].
In Baden-Wuerttemberg, the largest health insurer
(AOK) covers about 40% of the population. For more
than a decade, it has consistently developed and imple-
mented programs with financial incentives to strengthen
general practice and integration of medical care across
sectors and providers. Given its dominant position in
the region, this policy has shaped the structure of
healthcare in Baden-Wuerttemberg. The programs are
largely consistent with the vision of the German College
of General Practitioners (DEGAM) and was supported
by regional organization of GPs. The support for GP-
centred care in other physician organisations was mixed.
Enrollment in the program is a free choice for both
patients and physicians. According to regulations forle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
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Table 1 Description of the program to enhance general practice care on a framework for high-performing primary care [2]
Components of high-
performing primary care
General description Specific details
1 Engaged leadership GPCC is arranged in special contracts, which have
been developed by organisations of GPs in
collaboration with health insurers.
AOK, the largest health insurer in the region, initiated
the program together with the regional association of
GPs, and supported it over many years.
2 Data-driven improvement The physician participates in quality circles: small
groups of physicians who receive feedback on
their prescribing, evidence based information and
plan improvements. The practice has a data-orientated
quality system and decision support for prescribing
medication.
The AQUA-institute, Goettingen, is responsible for the
data-based feedback reports for physicians. GPs take
part in 4 quality circle meetings per year in which
benchmark reports with own prescribing data is
discussed under supervision of a trained peer moderator.
3 Empanelment The physician participates in disease management
programs (DMP) which concern panels of patients
with diabetes, asthma/COPD, and coronary heart disease.
Partipation by patients is voluntary and based on written
informed consent. After consent, patients are added to
the panel of patients in GP-centred care.
4 Team-based care Disease management programs imply enhanced
participation of practice assistants in clinical work.
Practice assistants are encouraged to take part in an
additional training program (VERAH) for better management
of patients with chronic diseases. Practices who have their
assistants qualified are entitled to receive a financial bonus.
5 Patient-team partnership Self-management support is an important component
of disease management programs.
Patients who participate in a DMP are offered a validated
educational program. This comprises of informative group
meetings.
6 Population management The decisions of the physician on pharmaceutical
treatment follow prevailing recommendations, for
instance regarding the prescription of discount drugs
and such with therapeutic benefit (using a software tool).
Feedback and benchmarking on prescribing is supported
by short written evidence reports. Recommendations are
strictly evidence-based and not influenced by industry.
Prompts in the software of a practice support use of generic
and discounted drugs where eligible.
7 Continuity of care Referrals to medical specialists are preceded by relevant
diagnostic procedures and treatments and, in case of
referral, the findings are clearly communicated to
medical specialists and backwards.
The contract with GPs is supported by contracts with
specialists such as cardiologists and orthopeadic surgeons
in which care pathways are stipulated.
8 Prompt access to care The practice organization of the physician has a number
of clinical facilities (e.g., spirometer), daily consultation
hours, up-to-date information technology. Patients
benefit from shorter waiting times and absence of
out-of-pocket payments for medication.
According to the contract practices have to have a
comprehensive set of up to date primary care equipment
available.
9 Comprehensiveness and
care coordination
The physician is trained in primary care-relevant
domains (e.g., pain treatment, communication skills)
and participates in continuing education.
A committee of the association of GPs and academic
departments of general practice in the area coordinates
continuing medical education and sets topics for quality
circle sessions for the participating GPs together with the
AQUA institute.
10 Template of future Participation in GPCC is a voluntary choice of physicians
and patients. For the FP, is associated with about 40%
increased reimbursement of the FP for enrolled patients
as lump sum payment without pre-specified maximum.
The GP-centred care program is planned to remain in
Baden-Wuerttemberg. Collaboration of primary care and
medical specialists will be strengthened by programs
targeted at ambulatory medical specialists.
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Five, the program is based on a contract between the re-
gional sickness fund (‘Allgemeine Ortskrankenkasse’,
AOK) and the association of GPs (‘Hausärzteverband’).
For the GP, it comes with about 40% additional reim-
bursement for included patients; there are no direct
financial incentives for included patients. An initial
evaluation (covering about 1.4 million patients in the
first two years) showed that patients enrolled were older
and had higher levels of comorbidity than patients in
usual care [3]. After adjustment for confounders, en-
rolled patients showed to have more visits to the GP and
fewer visits to medical specialists compared to usual
care. Number, costs and appropriateness of medicationprescribing had improved, while no impact on rates of
hospitalization and rehospitalization rates was found [3].
A major innovation such as this program to
strengthen general practice care is likely to be taken
up in practice gradually over a long period of time,
with most motivated practitioners and the best prac-
tice organizations as the first to get involved [4].
Thus, the impact of the program in later days might
be lower than in earlier years. Also, the impact in the
included patients over a longer period may be differ-
ent (most likely lower) as compared to patients who
have been enrolled for a short time, as easy improve-
ments are likely to have been made in the first period
after enrollment. The aim of the present study was to
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strengthen general practice care.
Methods
Study design
This was a comparative evaluation study, based on
two separate cross-sectional studies at 4 and 5 years
after its start (T1 and T2, respectively). This study
was based on data in computerized systems, which
are continuously collected for administrative control
and reimbursement purposes. Due to legal obligations,
the program was offered to all patients and primary
care providers, so random allocation to parallel study
groups was not possible. Ethical approval for the
study was given by the University Hospital Heidelberg
Ethics Committee (No. S-359/2013).
Setting
The project took place in Baden-Wuerttemberg,
Germany, a region with about 10.7 million inhabitants.
In Germany, approximately 90% of the population is
insured by statutory sick funds (the remaining 10% is
privately insured). Premiums are payed by employers
and employees. Co-payments such as for hospital stays
or medication are very low. Data were derived from
AOK Baden-Wuerttemberg, the largest health insurer in
the region (about 4 million insured persons). In 2015, a
total of about 1.4 million patients and about 3.500
primary care physicians participated in the program.
Study population
Patients were eligible to participate in the evaluation if
they met the following pre-defined criteria: aged 18 years
or older, living in Baden-Wuerttemberg in the observed
year, at least one visit to the primary care physician in
the relevant year, health insurance with AOK, no regis-
tration with different contracts (e.g., integrated care con-
tracts), no interruptions of registration in the relevant
year. Patients enrolled in the program (‘intervention
patients’) provided informed consent before participa-
tion. They were compared with all other eligible patients
in the observed year (‘control patients’). Control patients
met the same inclusion criteria as patients in the inter-
vention group. Control patients were linked post-hoc to
the primary care physician, whom they had visited in at
least 50% of their contacts in primary care. If no such
linkage was possible, they were excluded from analysis.
The exclusion criteria concerning the contacts to a par-
ticular GP was introduced, since for usual care patients,
there was no explicit link to their GPs in the data set.
Therefore, we determined patients’ GPs on the basis of
their GP contacts. Patients without GP contacts and pa-
tients that could not be assigned to a particular GP un-
ambiguously were excluded for analyses. The percentageof patients with this exclusion type for both observation
periods was 2.1%.Program description
The program had multiple components and was tar-
geted at multiple aims. Table 1 maps out the different
components of the program against a framework for
high-quality primary care [2]. Detailed specifications
can be found in the German Social Code, Book Five
(SGB V) §73b.Measures
Outcomes were chosen in consultation with stake-
holders, in particular AOK Baden-Wuerttemberg and
Association of GPs (Hausärzteverband). Criteria for
selection concerned relevance, changeability, and meas-
urability. More specifically, three questions were consid-
ered: a) Does the intervention focus on the target
variable directly or maybe indirectly, b) Is the target
variable relevant in the Health Services Research context
C) Can we expect internal validity for the target vari-
able? An expert panel determined the target variable set.
The AQUA Institute for Applied Quality Improvement
and Research in Health Care, Göttingen, Germany, has a
long term experience in verification and collation of
routine data and supported the University of Heidelberg
with that experience.
The following 11 outcomes were chosen: number of
visits to the primary care physician, the number of pa-
tients with polypharmacy (defined as > 5 drug agents),
the number of prescriptions that should be avoided on
the basis of evidence-based criteria and costs (drugs on
a so called ‘red list’), costs of medication therapy in
ambulatory care (covering primary and specialist ambu-
latory care), the number of contacts with medical spe-
cialists after referral (with and without referral of the
GP), the number of hospital admissions, the number of
potentially avoidable hospital admission, the number of
days in hospital, the number of hospital admissions
within weeks after a previous hospital admission, and
costs of hospital admissions.
A list of 107 variables was available for adjustment for
confounding of the comparison between groups. The
following patient factors were considered as potential
predictors based on subject matter knowledge and used
for adjustment: patient age, sex, morbidity in observa-
tion year (Charlson index [5]), nursing home as place of
living, need for nursing (a 4-point scale). GP’s participa-
tion in the program was included as well as a number of
practice characteristics: urbanization (rural, urban), prac-
tice size (number of contacts in relevant period), type of
practice (single, group). Data were derived from admin-
istrative databases held by AOK. Data-cleaning was
Table 2 Description of patient samples at T1 (n = 1187597) and T2 (n = 1591017)
4 years after start (year 2012) 5 years after start (year 2013)
Patients in GPCC
(n = 610985)
Patients in usual care
(n = 576612)
Patients in GPCC
(n = 823951)
Patients in usual care
(n = 767057)
Mean age in years (SD) 59.3 (17,5) 58.4 (18,3) 58.0 (18.4) 54.9 (19,8)
Women (%) 57.4 58.1 56.6 56.4
German nationality 87.2 86.5 85.7 84.1
Morbidity (mean Charlson index)(SD) 1.5 (2.0) 1.4 (1.9) 1.4 (2.0) 1.1 (1.8)
Stay in GPCC (in quarter years)(SD) 13.2 (2.5) – 15.6 (4.4) –
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ent of the analysis.
Data-analysis
Given the large sample size, no statistical power calcula-
tion was done. Comparison between patients included in
the program and non-included patients was done by
regression analysis, which took clustering of patients in
GPS and GPs in practices into account. Depending on
the distribution of each outcome, a linear regression
model or a Poisson regression model (for count data)
were used. The program effect on each of the outcomes
of interest was estimated using adjusted, multivariable
regression models. Bonferroni correction for multiple
testing was applied for the X estimated program effects.Table 3 Impact of the program at T1
Patients in GPCC
Primary care
Mean number of visits to the FP (SD) 14.32 (11.44)
Mean number of prescribed drugs (SD) 5.99 (5.29)
Mean percentage of prescriptions that
should be avoided per FP (SD)
4.53 (12.43)
Mean costs of medication therapy in
ambulatory care in observed year (euro) (SD)
1361.04 (62117.00
Mean number of contacts with medical
specialists with referral from FP (SD)
3.00 (3.11)
Mean number of contacts with medical
specialists without referral (SD)
1.93 (2.60)
Hospital care
Mean number of hospital admissions (SD) 0.272 (0.749)
Mean percentage of avoidable hospital
admissions of all admissions (SD)
15.25 (33.15)
Mean number of days in hospital (SD) 13.60 (17.18)
Mean number of hospital admissions within 4
weeks after a previous hospital admission. (SD)
0.200 (0.664)
Mean total costs of hospital admission in year
(euro) (SD)
5881.59 (8502.35)
aThe Standard Error and the 95%-Confidence Interval is reported on the logarithmic
The italicize figures indicate statistical significanceUsing a nominal significance level of 5%, the Bonferroni-
corrected significance level was 0.05/X and p values falling
below this level were considered statistically significant.
Results
Data on 1.187.597 and 1.591.017 eligible patients were
available for the analysis for T1 and T2, respectively.
Table 2 describes the patient populations. Participants
were slightly older than non-participants, but gender,
morbidity, and proportion with German nationality were
roughly equal in both groups in both years.
Tables 3 and 4 present the data on outcomes. Compared
to usual care, the program was associated with more visits
to the FP, more patients with polypharmacy, fewer
patients with drugs that should be avoided, and lowerPatients in usual care Adjusted difference (SE) [95% CI]
8.83 (9.83) +3.75
(0.177) [3,41; 4,10]
5.85 (5.21) +0.051
(0.029) [−0.006; 0.108]
5.92 (14.80) −1.186
(0.067) [−1.314; −1.051]
) 1411.67 (46379.79) −113.20
(0.021) [−0.107; −0.054]a
4.06 (4.46) −1.01
(0.026) [−1.066; −0.962]
2.21 (2.90) −0.325
(0.02) [−0.365; −0.286]
0.285 (0.774) −0.008
(0.008) [−0.044; −0.014]a
16.05 (33.83) −1.263
(0.173) [−1.602; −0.923]
14.04 (18.02) −0.008
(0.008) [−0.180; 0.164]
0.205 (0.692) −0.004
(0.017) [−0.012; 0.055]
5848.46 (8349.58) +116.40
(0.021) [0.010; 0.033]a
scale according to the used link function of the particular model
Table 4 Impact of the program at T2
Patients in GPCC Patients in usual care Adjusted difference
(SE) (95% CI)
Primary care
Mean number of visits to the FP (SD) 12.28 (10.85) 8.33 (10.14) +1.98 (0.163)
[1.659; 2.297]
Mean number of prescribed drugs (SD) 5.99 (5.09) 5.41 (5.14) +0.071 (0.022)
[0.028; 0.116]
Mean percentage of prescriptions that
should be avoided per FP (SD)
2.23 (9.96) 3.20 (11.44) −0.699 (0.041)
[−0.779; −0.619]
Mean costs of medication therapy in
ambulatory care in observed year (euro) (SD)
1371.43 (72.10) 1396.32 (61.72) −85.39 (0.009)
[−0.064; −0.028]a
Mean number of contacts with medical
specialists with referral from FP (SD)
4.97 (8.50) 4.96 (8.02) −0.455 (0.013)
[−0.480; −0.428]
Mean number of contacts with medical
specialists without referral (SD)
2.32 (7.45) 3.42 (9.46) −1.528 (0.076)
[−1.667; −1.378]
Hospital care
Mean number of hospital admissions (SD) 0.288 (0.786) 0.290 (0.794) −0.017 (0.006)
[−0.085; −0.061]a
Mean percentage of avoidable hospital
admissions of all admissions (SD)
15.69 (33.64) 16.32 (33.96) −1.165 (0.145)
[−0.880; −1.449]
Mean number of days in hospital (SD) 14.14 (18.13) 14.41 (19.08) −0.438 (0.083)
[−0.276; −0.599]
Mean number of hospital admissions within
4 weeks after a previous hospital admission. (SD)
0.255 (0.710) 0.233 (0.739) −0.007 (0.012)
[−0.070; −0.020]
Mean total costs of hospital admission in
year (euro) (SD)
6476.29 (9939.46) 6397.86 (10393.27) −44.30 (0.003)
[−0.017; −0.002]a
aThe Standard Error and the 95%-Confidence Interval is reported on the logarithmic scale according to the used link function of the particular model
The italicize figures indicate statistical significance
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ambulatory specialists, either with or without referral from
a GP was reduced at T2, but not at T1. In hospital care,
the program was associated with fewer hospital admis-
sions and fewer avoidable hospital admissions in both
years. Total hospital costs were slightly higher at T1, but
lower at T2 for patients in the program. Days in hospital
and number of readmissions were lower among patients
in the program at T2, but not at T1.Discussion
Patients who chose to be included in the program of
intensified general practice care were compared to pa-
tients who chose not to be included, adjusted for a large
number of patient characteristics. Four and five years
after its start, participation in the program was consist-
ently associated with more intensive use of general prac-
tice care, fewer drugs prescribed that should be avoided,
lowered medication costs, and fewer hospital admissions.
As the program reached a large patient population in
routine practice, the benefits for the healthcare system
are substantial. We conclude that the program has ef-
fectively strengthened general practice care for patients
included in the program.Observational research showed that conditions for
providing high-quality chronic care differ widely between
practice organisations and between countries [6]. This
German program to enhance general practice care is in
many ways comparable to medical homes in the United
States. A study in 29 practices of the implementation of
medical home with shared savings in Pennsylvania, U.S.,
showed higher rates of primary care visits and lowered
rates of ambulatory visits to specialists, fewer emergency
department visits, and fewer hospital admissions [7].
These findings are largely similar to the results of our
study. The healthcare systems in Germany and the United
States share a number of characteristics, such as lack of
coordination and the presence financial incentives for
overtreatment, so that programs to position GPs in a
coordinating role have high chances to achieve improve-
ments in quality and outcomes of healthcare.
The findings of our study are also consistent with
macro-level studies, which suggested that patients with
chronic diseases receive better care in countries with well-
developed primary care. For instance, this was found in an
international study that considered aspects of structure,
accessibility, continuity, coordination, and comprehensive-
ness of primary care [8]. All these aspects were targeted
by the GP-centred care program. The observation that the
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higher in the program might be explained by a lack of
communication between specialists and GPs about pre-
scribing issues. This could lead to overlapping of prescrib-
ing with increasing consultation rates.
Our study was based on a large data-set, advanced
quantitative and statistical modelling, and included repli-
cation of findings by separate analysis on data from two
years. It is important to interpret the findings in relation
to the study design: we compared patients who chose to
be included in the program of intensified general prac-
tice care with patients who chose not to be included.
Only patients who actually visited the practice in the
observed period were included, because this was neces-
sary to link them to a particular GP in this analysis of
claims data. Claims about the effectiveness of the pro-
gram as such have high risk of bias, because we cannot
rule out selection bias, despite the extensive adjustment
in the multivariate analyses.
In addition, the program comprised of a complex set of
interventions (financial incentives, quality circles, data-
based feedback, software tool with traffic lights system for
prescribing drugs, discount drugs) and our study was not
designed to unravel the relative impact of its different
components or the fidelity of their implementation. Our
intention is to analyse trends over longer periods of time
in future research, ideally with historical controls (before
the program started). The generalizability may be limited
by its focus on Baden-Wuerttemberg, a relatively wealthy
state in Germany. However, people insured by AOK tend
to be less wealthy, so we think that the generalizability is
reasonably good.
Future research should include process evaluation,
which explores the added value of different components
of the program. The added payment seems crucial to get
a large number of healthcare providers involved in the
program, but it does not improve quality or outcomes of
healthcare by itself. Healthcare providers have responded
to these financial incentives, but how exactly is largely
unclear. Organizing healthcare delivery in a more struc-
tured way has stimulated that patients receive all items
of recommended healthcare. A weaker aspect of the GP-
centred care program is the degree of support for
patients’ self-management of health and disease, as this
mainly comprises of traditional patient education. The
overall impact on health outcomes may be higher, if
modern tools to enhance patient self-management
would be included.
The study supports the policy of various stakeholders
in Baden-Wuerttemberg to strengthen primary care.
Although attribution of outcomes to interventions
should be carefully done, the routine care setting and
size of the study lend support to this claim. It may be
noted that primary care in Germany is moderatelystrong, like in many parts of the United States. The
generalizability may be best to countries, which are
similar to Germany regarding primary care. Future
research should also focus on in-depth analysis of the
added value of different components of the program
and on its impact on clinical processes and outcomes.
Nevertheless, the study suggests that a comprehensive
package of interventions can effectively strengthen
general practice care.
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